About NanoVibronix
NanoVibronix is a company based in Elmsford (United States) founded in 2003. NanoVibronix has raised $10.89 million across 18 funding rounds. The company has 31 employees as of December 31, 2024. NanoVibronix offers products and services including PainShield and UroShield. NanoVibronix operates in a competitive market with competitors including Camstent, BioDerm, ProvenMed, Aurie and FLUME, among others.
- Headquarter Elmsford, United States
- Employees 31 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nanovibronix, Inc.
-
Annual Revenue
$2.56 M (USD)12.05as on Dec 31, 2024
-
Net Profit
-$3.71 M (USD)0.16as on Dec 31, 2024
-
EBITDA
-$3.58 M (USD)-4.25as on Dec 31, 2024
-
Total Equity Funding
$10.89 M (USD)
in 18 rounds
-
Latest Funding Round
$50 M (USD), Post-IPO
Jul 18, 2025
-
Investors
Not available
-
Employee Count
31
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NanoVibronix
NanoVibronix is a publicly listed company on the NASDAQ with ticker symbol NAOV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NanoVibronix
NanoVibronix offers a comprehensive portfolio of products and services, including PainShield and UroShield.
Wearable ultrasound for treating chronic pain and soft tissue damage.
Ultrasound device to reduce bacterial colonization and urinary infections.
People of NanoVibronix
Unlock access to complete
Unlock access to complete
Funding Insights of NanoVibronix
NanoVibronix has successfully raised a total of $10.89M across 18 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by NanoVibronix
Investment portfolio details for NanoVibronix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NanoVibronix
Detailed financials for NanoVibronix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanovibronix Comparisons
Peer comparison for NanoVibronix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NanoVibronix
NanoVibronix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Camstent, BioDerm, ProvenMed, Aurie and FLUME, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Polymer coating for medical devices
|
|
| Locked | Locked | Locked |
Hydrocolloid products are developed for urinary management and skin protection.
|
|
| Locked | Locked | Locked |
Devices for urinary incontinence treatment are provided by ProvenMed.
|
|
| Locked | Locked | Locked |
Automated reusable self-catheter systems are developed for urinary retention patients.
|
|
| Locked | Locked | Locked |
Developer of a catheter for the treatment of urinary incontinence
|
Detailed competitors of NanoVibronix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanovibronix
Complete news archive for NanoVibronix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NanoVibronix
NanoVibronix was founded in 2003.
NanoVibronix is headquartered in Elmsford, United States. It is registered at Elmsford, New York, United States.
Harold Jacob is the current CEO of NanoVibronix.
NanoVibronix is a funded company, having raised a total of $10.89M across 18 funding rounds to date.
As of Dec 31, 2024, the latest employee count at NanoVibronix is 31.
Annual revenue of NanoVibronix is $2.56M as on Dec 31, 2024.
NanoVibronix was founded in 2003 and is headquartered in Elmsford, United States. Ultrasound therapy devices are developed using proprietary low-frequency, low-intensity acoustic wave technology. Disposable transducers are utilized to transmit waves that aid in pain elimination, musculoskeletal and vascular tissue regeneration, and biofilm reduction on urinary catheters to lower CAUTI risks. Operations focus on the medical device sector for various therapeutic applications.
NanoVibronix offers PainShield and UroShield.
Yes, NanoVibronix is publicly traded on NASDAQ under the ticker symbol NAOV.
The ticker symbol of NanoVibronix is NAOV on NASDAQ.